$50 Million

Clearside Biomedical

At-the-market Offering

Clearside Biomedical
Clearside BioMedical is a late-stage clinical biopharmaceutical company developing drug therapies to treat blinding diseases of the eye. Its product candidates are injected into the suprachoroidal space (SCS) using its proprietary SCS Microinjector.